IP Library Granted Patent US 8,523,856
Granted Patent B2
US 8,523,856 · App. 13/604,160 · Granted Sep 3, 2013

Hemostasis device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,523,856
App. No.
13/604,160
Granted
Sep 3, 2013
Kind
B2
Abstract

A method and system for achieving hemostasis (the stoppage of bleeding) is described. RF (radio frequency) energy is used to ablate the surface of tissue to stop bleeding. The depth of destruction of the tissue can be controlled so as to desiccate and coagulate the tissue. In one implementation, an electrode carrier including bipolar electrodes is applied to the tissue, and RF energy transmitted through the bipolar electrodes to ablate the tissue. A layer of desiccated tissue can be created as well as coagulation of the tissue to achieve hemostasis.

Claims (13)

1. A method for blood coagulation, comprising:

positioning a hemostasis device in contact with bleeding tissue, the hemostasis device including a porous layer, a vacuum line and an electrode, wherein the vacuum line is included within the porous layer, and wherein the vacuum line is operably coupled to a vacuum source;

activating the vacuum source to draw the bleeding tissue into contact with the porous layer and the electrode and to draw moisture released from the tissue during ablation away from the electrode;

activating a source of energy and delivering energy to the electrode and ablating the tissue in contact with electrode; and

ceasing delivery of the energy upon reaching a desired depth of destruction of the tissue;

wherein hemostasis is substantially achieved in a region of the ablation.

2. The method of claim 1 further comprising controlling the delivery of energy based on an impedance of the tissue near the electrode.

3. The method of claim 2 , further comprising directing the flow of energy through the tissue.

4. The method of claim 1 further comprising controlling the delivery of energy based on user input.

5. The method of claim 1 , further comprising separating the hemostasis device from the tissue without restarting bleeding.

6. The method of claim 1 , wherein the hemostasis device includes a plurality of electrodes.

7. The method of claim 6 , further comprising ceasing the delivery of energy based on a threshold impedance between the plurality of electrodes.

8. The method of claim 6 , further comprising activating less than all of the plurality of electrodes.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 029340/0249 Recorded Jul 17, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 036128/0001 →
FIRST SUPPLEMENT TO PATENT SECURITY AGREEMENT Recorded Nov 20, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 029340/0249 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2012
From: SAMPSON, RUSSEL M.; SKALNYI, EUGENE V.
To: CYTYC CORPORATION
Reel/Frame 028927/0105 →